Annual Gross Margin
84.30%
+7.50%+9.77%
December 31, 2024
Summary
- As of February 25, 2025, HALO annual gross profit margin is 84.30%, with the most recent change of +7.50% (+9.77%) on December 31, 2024.
- During the last 3 years, HALO annual gross margin has risen by +2.66% (+3.26%).
- HALO annual gross margin is now -15.31% below its all-time high of 99.54%, reached on December 31, 2011.
Performance
HALO Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Margin
85.89%
+2.93%+3.53%
December 31, 2024
Summary
- As of February 25, 2025, HALO quarterly gross profit margin is 85.89%, with the most recent change of +2.93% (+3.53%) on December 31, 2024.
- Over the past year, HALO quarterly gross margin has stayed the same.
- HALO quarterly gross margin is now -14.07% below its all-time high of 99.95%, reached on September 30, 2011.
Performance
HALO Quarterly Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Margin Formula
Gross Margin = Gross Profit
Revenue ✕ 100%
Revenue ✕ 100%
HALO Gross Margin Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +9.8% | 0.0% |
3 y3 years | +3.3% | +15.1% |
5 y5 years | +9.8% | +15.1% |
HALO Gross Margin Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +9.8% | -0.6% | +15.1% |
5 y | 5-year | at high | +9.8% | -6.1% | +24.6% |
alltime | all time | -15.3% | +135.7% | -14.1% | +4780.1% |
Halozyme Therapeutics Gross Margin History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | 84.30%(+9.8%) | 85.89%(+3.5%) |
Sep 2024 | - | 82.96%(+0.1%) |
Jun 2024 | - | 82.88%(-3.1%) |
Mar 2024 | - | 85.54%(+10.7%) |
Dec 2023 | 76.80%(-2.7%) | 77.27%(+3.6%) |
Sep 2023 | - | 74.62%(-3.5%) |
Jun 2023 | - | 77.35%(-1.2%) |
Mar 2023 | - | 78.31%(+2.0%) |
Dec 2022 | 78.90%(-3.4%) | 76.79%(-0.7%) |
Sep 2022 | - | 77.36%(-0.5%) |
Jun 2022 | - | 77.72%(-10.1%) |
Mar 2022 | - | 86.42%(+9.6%) |
Dec 2021 | 81.64%(-2.6%) | 78.84%(-6.1%) |
Sep 2021 | - | 83.95%(+1.0%) |
Jun 2021 | - | 83.13%(+4.5%) |
Mar 2021 | - | 79.53%(+1.4%) |
Dec 2020 | 83.79%(+9.2%) | 78.41%(-14.3%) |
Sep 2020 | - | 91.48%(+2.1%) |
Jun 2020 | - | 89.61%(+16.1%) |
Mar 2020 | - | 77.18%(+12.0%) |
Dec 2019 | 76.76%(-17.8%) | 68.91%(+33.3%) |
Sep 2019 | - | 51.69%(-45.7%) |
Jun 2019 | - | 95.21%(+3.7%) |
Mar 2019 | - | 91.84%(+1.3%) |
Dec 2018 | 93.33%(+3.5%) | 90.67%(-7.1%) |
Sep 2018 | - | 97.55%(-0.1%) |
Jun 2018 | - | 97.63%(+8.3%) |
Mar 2018 | - | 90.11%(-6.2%) |
Dec 2017 | 90.16%(+16.5%) | 96.05%(+10.5%) |
Sep 2017 | - | 86.93%(+13.0%) |
Jun 2017 | - | 76.92%(+3.3%) |
Mar 2017 | - | 74.49%(-6.3%) |
Dec 2016 | 77.36%(-1.3%) | 79.48%(+11.4%) |
Sep 2016 | - | 71.32%(-5.0%) |
Jun 2016 | - | 75.08%(-8.1%) |
Mar 2016 | - | 81.74%(-2.5%) |
Dec 2015 | 78.35%(+12.2%) | 83.86%(+19.4%) |
Sep 2015 | - | 70.26%(-13.5%) |
Jun 2015 | - | 81.23%(+24.6%) |
Mar 2015 | - | 65.21%(-18.2%) |
Dec 2014 | 69.83% | 79.76%(+23.1%) |
Sep 2014 | - | 64.80%(-4.4%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2014 | - | 67.78%(+25.8%) |
Mar 2014 | - | 53.87%(-24.8%) |
Dec 2013 | 88.60%(-9.1%) | 71.68%(-25.1%) |
Sep 2013 | - | 95.73%(+5.1%) |
Jun 2013 | - | 91.12%(-2.8%) |
Mar 2013 | - | 93.76%(-3.3%) |
Dec 2012 | 97.42%(-2.1%) | 97.00%(+1.3%) |
Sep 2012 | - | 95.75%(-2.5%) |
Jun 2012 | - | 98.16%(-0.9%) |
Mar 2012 | - | 99.05%(+1.4%) |
Dec 2011 | 99.54%(+7.3%) | 97.67%(-2.3%) |
Sep 2011 | - | 99.95%(+0.7%) |
Jun 2011 | - | 99.23%(-0.6%) |
Mar 2011 | - | 99.84%(+32.9%) |
Dec 2010 | 92.77%(-5.1%) | 75.12%(-24.7%) |
Sep 2010 | - | 99.79%(+2.5%) |
Jun 2010 | - | 97.40%(-2.4%) |
Mar 2010 | - | 99.84%(+2.4%) |
Dec 2009 | 97.72%(+1.6%) | 97.52%(+0.9%) |
Sep 2009 | - | 96.61%(-0.2%) |
Jun 2009 | - | 96.84%(-3.0%) |
Mar 2009 | - | 99.85%(+4.2%) |
Dec 2008 | 96.21%(+2.7%) | 95.84%(+1.2%) |
Sep 2008 | - | 94.69%(-2.8%) |
Jun 2008 | - | 97.41%(-0.5%) |
Mar 2008 | - | 97.94%(+0.1%) |
Dec 2007 | 93.67%(+68.8%) | 97.82%(+4.4%) |
Sep 2007 | - | 93.69%(+4.9%) |
Jun 2007 | - | 89.34%(-1.4%) |
Mar 2007 | - | 90.59%(+0.3%) |
Dec 2006 | 55.49%(-6.2%) | 90.29%(+5030.1%) |
Sep 2006 | - | 1.76%(-98.0%) |
Jun 2006 | - | 86.18%(+25.5%) |
Mar 2006 | - | 68.67%(+9.6%) |
Dec 2005 | 59.15%(+65.4%) | 62.67%(+3.3%) |
Sep 2005 | - | 60.65%(+12.3%) |
Jun 2005 | - | 54.00%(-27.0%) |
Dec 2002 | - | 74.01%(-5.6%) |
Sep 2002 | - | 78.36%(+1626.0%) |
Jun 2002 | - | 4.54%(-95.0%) |
Mar 2002 | - | 90.32% |
Dec 2001 | 35.76% | - |
FAQ
- What is Halozyme Therapeutics annual gross profit margin?
- What is the all time high annual gross margin for Halozyme Therapeutics?
- What is Halozyme Therapeutics annual gross margin year-on-year change?
- What is Halozyme Therapeutics quarterly gross profit margin?
- What is the all time high quarterly gross margin for Halozyme Therapeutics?
- What is Halozyme Therapeutics quarterly gross margin year-on-year change?
What is Halozyme Therapeutics annual gross profit margin?
The current annual gross margin of HALO is 84.30%
What is the all time high annual gross margin for Halozyme Therapeutics?
Halozyme Therapeutics all-time high annual gross profit margin is 99.54%
What is Halozyme Therapeutics annual gross margin year-on-year change?
Over the past year, HALO annual gross profit margin has changed by +7.50% (+9.77%)
What is Halozyme Therapeutics quarterly gross profit margin?
The current quarterly gross margin of HALO is 85.89%
What is the all time high quarterly gross margin for Halozyme Therapeutics?
Halozyme Therapeutics all-time high quarterly gross profit margin is 99.95%
What is Halozyme Therapeutics quarterly gross margin year-on-year change?
Over the past year, HALO quarterly gross profit margin has changed by 0.00% (0.00%)